(196 days)
Not Found
No
The summary describes a silver-plated fabric wound dressing and its performance testing, with no mention of AI or ML.
Yes
The device is indicated for use in treating various types of wounds, including diabetic ulcers and burns, which are therapeutic applications.
No
The device description and intended use indicate that TheraBond Antimicrobial Barrier Systems are wound dressings used for treatment and protection, not for diagnosing medical conditions.
No
The device description clearly states it is a "knitted, flexible, silver-plated nylon-based fabric," which is a physical material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes the device as a wound dressing for various types of wounds. This is a topical application for treating the wound itself, not for analyzing a sample from the body to diagnose a condition.
- Device Description: The device is described as a fabric-based wound dressing. IVDs are typically reagents, instruments, or systems used to examine specimens from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Performance Studies: The performance studies focus on antimicrobial effectiveness, silver release, plating integrity, and biocompatibility – all relevant to a wound dressing, not an IVD.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, diagnostic purposes, or any of the typical components or functions of an IVD.
Therefore, the TheraBond Antimicrobial Barrier Systems are a medical device intended for wound care, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
TheraBond Antimicrobial Barrier Systems are indicated for use in light to moderately exuding partial and full thickness wounds including traumatic wounds, surgical wounds, donor sites, 1st and 2nd degree burns, as well as decubitus ulcers, diabetic ulcers and vascular ulcers. TheraBond may be used over debrided and partial thickness wounds.
Product codes (comma separated list FDA assigned to the subject device)
FRO
Device Description
The TheraBond Antimicrobial Barrier Systems consist of a knitted, flexible, silver-plated nylon-based fabric. The device is available in several sizes and configurations including wound contact dressings, island dressings and wraps.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data provided in support of this submission include the results of antimicrobial effectiveness testing, silver ion release testing, silver plating integrity testing and biocompatibility testing in accordance with ISO 10993: Biological Evaluation of Medical Devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
N/A
0
Traditional 510(k) Premarket Notification November 12, 2007
K073213
page 1 of 1
Section 5-510(k) Summary
Owner's Name: Address:
Telephone Number: Fax Number: Contact Person:
Subject Device Name: Trade Name: Common/Usual Name: Product Code: FDA Regulation: Device Classification:
Predicate Devices:
Trade Name: Common/Usual Name: Product Code: FDA Regulation: Device Classification:
Choice Therapeutics MAY 2 8 2008 One Apple Hill Road, Suite 316 Natick, MA 01760 (508) 720-9803 (508) 650-0260 Peter Hamilton, Vice President of Operations
TheraBond Antimicrobial Barrier Systems TheraBond Wound Dressing (Antimicrobial) FRO - Dressing, Wound, Drug N/A Unclassified
K981299: Silverlon Contact Wound Dressing (Argentum International, LLC) K023612: Antimicrobial Barrier Wound Contact Dressing, Burn Wrap, Burn Contact Dressing & Silverlon Acute Burn Glove (Argentum International, LLC) Silverlon Wound Dressing (Antimicrobial) FRO - Dressing, Wound, Drug N/A Unclassified
Device Description
The TheraBond Antimicrobial Barrier Systems consist of a knitted, flexible, silver-plated nylon-based fabric. The device is available in several sizes and configurations including wound contact dressings, island dressings and wraps.
Intended Use
TheraBond Antimicrobial Barrier Systems are indicated for use in light to moderately exuding partial and full thickness wounds including traumatic wounds, surgical wounds, donor sites, 1st and 2nd degree burns, as well as decubitus ulcers, diabetic ulcers and vascular ulcers. TheraBond may be used over debrided and partial thickness wounds.
Performance Testing
Performance data provided in support of this submission include the results of antimicrobial effectiveness testing, silver ion release testing, silver plating integrity testing and biocompatibility testing in accordance with ISO 10993: Biological Evaluation of Medical Devices.
Conclusion
TheraBond Antimicrobial Barrier Systems meet all pre-determined acceptance criteria of the testing performed to confirm safety and effectiveness for its intended use; the TheraBond Antimicrobial Barrier Systems are substantially equivalent to the predicate devices.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes extending from its back, representing the department's commitment to health and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle, emphasizing the department's role within the United States government. The logo is simple, yet recognizable, and is often used on official documents and websites related to health and human services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 28 2008
Choice Therapeutics % Hogan & Hartson LLP Mr. Howard M. Holstein Columbia Square 555 Thirteenth Street, Northwest Washington, District of Columbia 20004
Re: K073213
Trade/Device Name: TheraBond Antimicrobial Barrier Systems Regulatory Class: Unclassified Product Code: FRO Dated: May 6, 2008 Received: May 6, 2008
Dear Mr. Hostein:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Mr. Howard M. I-Iolstein
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Milham
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Section 4 - Indications for Use Statement
510(k) Number (if known): K073213
Device Name:
TheraBond Antimicrobial Barrier Systems
Indications for Use:
TheraBond Antimicrobial Barrier Systems are indicated for use in light to moderately exuding partial and full thickness wounds including traumatic wounds, surgical wounds, donor sites, 1st and 2nd degree burns, as well as decubitus ulcers, diabetic ulcers and vascular ulcers. TheraBond may be used over debrided and partial thickness wounds.
Prescription Use X (Per 21 CFR 801 Subpart D) OR
Over-the -Counter Use (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
NIL/RP Ogden for rkn
(Division Sign-Off)
Division of General, Restorative. and Neurological Devices
510(k) Number_K073213